Sperm bank market seen reaching $6.9B by 2033

Persistence Market Research says the global sperm bank market is set to grow from $5.3 billion in 2026 to $6.9 billion by 2033, driven by fertility preservation, assisted reproductive technologies and rising infertility. North America remains the largest regional market, while donor sperm services lead demand.

Why it matters: - The sperm bank market is tied to broader access to fertility care, delayed parenthood and infertility treatment. - Growth in sperm banking supports patients seeking fertility preservation before cancer treatment and other medical care. - The market’s expansion also reflects rising acceptance of donor insemination across single-parent and LGBTQ+ family planning.

What happened: - Persistence Market Research projects the global sperm bank market will rise from US$ 5.3 billion in 2026 to US$ 6.9 billion by 2033. - The forecast implies a 3.8% compound annual growth rate during 2026-2033. - The report was released July 23, 2026. - The report says North America leads the market, with Europe also important and Asia Pacific emerging as a growth region. - The report identifies donor sperm services as the leading segment.

The details: - Rising use of assisted reproductive technologies is creating steady demand for sperm banking services. - Fertility preservation awareness among cancer patients and people delaying parenthood is supporting demand. - Advances in cryopreservation, specimen storage and genetic screening are improving storage quality and treatment outcomes. - Investments in fertility clinics and reproductive healthcare infrastructure are widening market capacity. - Fertility clinics are the dominant end-user segment because of patient volume and expanding reproductive services. - Hospitals, specialty reproductive centers and research institutions also contribute to demand. - Digital donor databases and streamlined screening processes are improving service efficiency. - Advanced cryogenic storage technology helps preserve specimen viability over the long term. - The report names California Cryobank, Fairfax Cryobank, Cryos International, Xytex Corporation, Seattle Sperm Bank, New England Cryogenic Center, European Sperm Bank, London Sperm Bank, Indian Spermtech and Androcryos as key players. - The release includes a free report sample, customization option and full report checkout page.

Between the lines: - The forecast points to a market that is becoming more mainstream as reproductive healthcare shifts from a niche service to a long-term planning tool. - Regulation and donor anonymity rules remain a major barrier because requirements vary widely by country. - High treatment costs, limited reimbursement and social stigma still slow adoption in some markets. - The most promising operational gains may come from AI-assisted donor matching, automated lab systems and digital patient tools.

What's next: - Fertility providers are likely to keep expanding clinic networks and digital screening systems. - Asia Pacific could capture more growth as healthcare access improves and medical tourism rises. - Market participants are likely to lean on partnerships between clinics, research groups and reproductive health providers. - Ongoing adoption of genetic testing and cryopreservation improvements should continue to support treatment outcomes.

The bottom line: - Sperm banking is moving from a specialized service toward a broader reproductive health category, and the market outlook remains steady through 2033.